CD8A and hepatocellular carcinoma: TREM2+ TAMs play a crucial role in suppressing CD8+ T cells, and TREM2 deficiency can enhance the therapeutic effect of anti-PD-L1 blockade by increasing the antitumor activity of CD8+ T cells in hepatocellular carcinoma 9.